162 related articles for article (PubMed ID: 29806596)
1. Gastric adenocarcinoma expressing human epidermal growth factor receptor in South Asian population.
Shabbir A; Qureshi MA; Khalid AB; Mirza T; Shaikh A; Hasan SM
Saudi J Gastroenterol; 2018; 24(5):289-293. PubMed ID: 29806596
[TBL] [Abstract][Full Text] [Related]
2. Frequency of Her2/neu expression in colorectal adenocarcinoma: a study from developing South Asian Country.
Shabbir A; Mirza T; Khalid AB; Qureshi MA; Asim SA
BMC Cancer; 2016 Nov; 16(1):855. PubMed ID: 27821098
[TBL] [Abstract][Full Text] [Related]
3. The Expression of p53, CD44, Ki-67, and HER-2/neu Markers in Gastric Cancer and Its Association with Histopathological Indicators: A Retrospective Study.
Ahadi M; Moradi A; Musavinejad L; Movafagh A; Moradi A
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1607-1614. PubMed ID: 32592354
[TBL] [Abstract][Full Text] [Related]
4. Frequency of HER2/neu overexpression in adenocarcinoma of the gastrointestinal system.
Farzand S; Siddique T; Saba K; Bukhari MH
World J Gastroenterol; 2014 May; 20(19):5889-96. PubMed ID: 24914350
[TBL] [Abstract][Full Text] [Related]
5. HER-2/neu amplification is an independent prognostic factor in gastric cancer.
Park DI; Yun JW; Park JH; Oh SJ; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Yoo CH; Son BH; Cho EY; Chae SW; Kim EJ; Sohn JH; Ryu SH; Sepulveda AR
Dig Dis Sci; 2006 Aug; 51(8):1371-9. PubMed ID: 16868827
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic and prognostic significance of overexpression of her-2/neu and p53 oncoproteins in gastric carcinoma using tissue microarray.
Ismail HM; Moneer M; El-Baradie M; Khorshid O; Touny A
J Egypt Natl Canc Inst; 2007 Jun; 19(2):147-57. PubMed ID: 19034345
[TBL] [Abstract][Full Text] [Related]
7. [Association of HER-2/neu expression with prognosis of gastric cancer].
Chen B; Luo RC; Cui F; Qian XY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):344-7. PubMed ID: 16546744
[TBL] [Abstract][Full Text] [Related]
8. Study of the Relationship between MMP-2 and MMP-9 and Her2/neu Overexpression in Gastric Cancer: Clinico- Pathological Correlations.
Jafari E; Safinejad S; Dabiri S; Naghibzadeh-Tahami A
Asian Pac J Cancer Prev; 2021 Mar; 22(3):811-817. PubMed ID: 33773545
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of HER2/neu expression in primary gastroesophageal adenocarcinomas using conventional light microscopy and quantitative image analysis.
Jeung J; Patel R; Vila L; Wakefield D; Liu C
Arch Pathol Lab Med; 2012 Jun; 136(6):610-7. PubMed ID: 22646266
[TBL] [Abstract][Full Text] [Related]
10. Alteration in key oncoprotein expression in gastric adenocarcinoma - An immunohistochemical study.
Jain P; Wadhwa N; Diwaker P; Joshi MK; Mishra K
J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147954
[TBL] [Abstract][Full Text] [Related]
11. Expression of Human Epidermal Growth Factor Receptor (Her 2/neu) and Proliferative Marker Ki-67: Association with Clinicopathological Parameters in Gallbladder Carcinoma.
Pujani M; Makker I; Makker A; Jetley S; Goel MM; Jetley S
Asian Pac J Cancer Prev; 2016; 17(8):3903-9. PubMed ID: 27644637
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of HER-2/neu overexpression in gastric carcinoma using a tissue microarray.
Rakhshani N; Kalantari E; Bakhti H; Sohrabi MR; Mehrazma M
Asian Pac J Cancer Prev; 2014; 15(18):7597-602. PubMed ID: 25292034
[TBL] [Abstract][Full Text] [Related]
13. Human epidermal growth factor receptor 2 expression in gastric carcinoma and its association with histopathological parameters in Indian population.
Gupta P; Rao S; Bhalla S
Indian J Cancer; 2016; 53(4):505-511. PubMed ID: 28485339
[TBL] [Abstract][Full Text] [Related]
14. Immuno-Histochemical Assessment of HER2NEU Expression in Gastric Adenocarcinoma in North Karnataka, India.
Nadaf AS; Rani H; Dinesh US
Asian Pac J Cancer Prev; 2018 May; 19(5):1381-1385. PubMed ID: 29802704
[TBL] [Abstract][Full Text] [Related]
15. Analysis of epithelial-cadherin and human epidermal growth factor receptor 2/ expression in gastric carcinoma using immunohistochemistry.
Dewan K; Madan R; Sengupta P; Bharadwaj R
Indian J Pathol Microbiol; 2015; 58(2):154-7. PubMed ID: 25885125
[TBL] [Abstract][Full Text] [Related]
16. Significance of TFF3 protein and Her-2/neu status in patients with gastric adenocarcinoma.
Xu CC; Yue L; Wei HJ; Zhao WW; Sui AH; Wang XM; Qiu WS
Pathol Res Pract; 2013 Aug; 209(8):479-85. PubMed ID: 23822993
[TBL] [Abstract][Full Text] [Related]
17. [Expression of HER-2 and leptin in gastric cancer and their clinical significance].
Geng YT; Qiu JR; Wang R; Su YT; Shu YQ; Yin YM
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):764-9. PubMed ID: 22335909
[TBL] [Abstract][Full Text] [Related]
18. Prognosis significance of HER-2/neu overexpression/amplification in Chinese patients with curatively resected gastric cancer after the ToGA clinical trial.
Zhou F; Li N; Jiang W; Hua Z; Xia L; Wei Q; Wang L
World J Surg Oncol; 2012 Dec; 10():274. PubMed ID: 23249720
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic Implications of Eukaryotic Initiation Factor 3f and Her-2/neu Expression in Gastric Cancer.
Cheng Y; Zhou J; Li H
Clin Transl Sci; 2015 Aug; 8(4):320-5. PubMed ID: 25684180
[TBL] [Abstract][Full Text] [Related]
20. Serum level of HER-2/neu in patients with gastric cancer: correlation with HER-2/neu overexpression in gastric carcinoma tissue.
Kono K; Naganuma H; Sekikawa T; Amemiya H; Takahashi A; Iizuka H; Matsumoto Y
Tumour Biol; 2000; 21(3):139-44. PubMed ID: 10754464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
